Proteonomix, Inc. (PROT.OB) recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.
Proteonomix is the majority shareholder in XGEN Medical LLC (”XGen”) with the balance held by an anonymous investor group. Proteonomix personnel were on the ground in the U.A.E. over the past weeks to work together with the Investor Group through the start up phase.
This wholly owned subsidiary will be the vehicle to conduct business in the GCC countries. XGen has filed the corporate papers and has established banking relations with a local bank both for receipt of the initial investment of $5 million and towards further financing expanded services in the region.
Discussions are now further encompassing both the construction of XGen’s own manufacturing and treatment facility within the U.A.E. and on funding phased trials for one or more of PROT proprietary cellular materials for treatment of disease.
Proteonomix, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.
For more information about this company please visit http://www.proteonomix.com
Fiserv, Inc. (NASDAQ:FISV) recently reported the final results of its previously announced on October 13, 2010 cash tender offer to purchase up to $250,000,000 aggregate principal amount of its outstanding 6.125% senior notes due 2012 (the “Notes”) (CUSIP No. 337738AF5 and ISIN No. US337738AF57).
The tender offer expired at 11:59 p.m., New York City time, on Tuesday, October 12, 2010. As of the Expiration Date, Notes with an aggregate principal amount of $554,143,000 have been tendered and not validly withdrawn.
Fiserv, Inc. is the leading global provider of information management and electronic commerce systems for the financial services industry, driving innovation that transforms experiences for financial institutions and their customers. Fiserv is ranked No. 1 on the FinTech 100 survey of top technology partners to the financial services industry.
Fossil, Inc. (NASDAQ:FOSL) recently reported it is losing its President and Chief Operating Officer Michael Barnes. Barnes is departing the Richardson-based retailer to serve Bermuda-based Signet Jewelers Limited as chief executive officer. He will join Signet on Dec. 1. Barnes has been with Fossil for more than 25 years and served on the leadership team that took the company public in 1993. Fossil has not made any announcements about who will replace Barnes after his departure.
Fossil, Inc. designs, develops, markets, and distributes fashion accessories worldwide.
Liberty Capital Group (NASDAQ:LCAPA) will release its third quarter earnings on Friday, November 5th at 12:00 p.m. (ET). Greg Maffei, Liberty Media’s President and CEO, will host the call. During the call, Mr. Maffei will discuss the company’s financial performance and outlook and may discuss the previously announced split-off of the Liberty Capital and Liberty Starz tracking stock groups.
Liberty Media owns interests in a broad range of electronic retailing, media, communications and entertainment businesses. Those interests are attributed to three tracking stock groups: (1) the Liberty Interactive group (Nasdaq: LINTA, LINTB), which includes Liberty Media’s interests in QVC, Provide Commerce, Backcountry.com, BUYSEASONS, Bodybuilding.com, IAC/InterActiveCorp, and Expedia, (2) the Liberty Starz group (Nasdaq: LSTZA, LSTZB), which includes Liberty Media’s interest in Starz Entertainment and Starz Media, LLC, and (3) the Liberty Capital group (Nasdaq: LCAPA, LCAPB), which includes all businesses, assets and liabilities not attributed to the Interactive group or the Starz group including its subsidiaries Atlanta National League Baseball Club, Inc., and TruePosition, Inc., Liberty Media’s interest in SIRIUS XM Radio, Inc., and minority equity investments in Time Warner Inc. and Live Nation.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)